Texas Permanent School Fund Purchases 371 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Texas Permanent School Fund boosted its position in shares of ICU Medical, Inc. (NASDAQ:ICUIGet Rating) by 2.6% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,508 shares of the medical instruments supplier’s stock after buying an additional 371 shares during the period. Texas Permanent School Fund owned approximately 0.06% of ICU Medical worth $2,385,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in ICUI. Quadrant Capital Group LLC grew its holdings in shares of ICU Medical by 81.5% in the first quarter. Quadrant Capital Group LLC now owns 118 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 53 shares in the last quarter. Covestor Ltd grew its stake in shares of ICU Medical by 86.4% in the 1st quarter. Covestor Ltd now owns 123 shares of the medical instruments supplier’s stock worth $27,000 after buying an additional 57 shares in the last quarter. Janiczek Wealth Management LLC grew its stake in shares of ICU Medical by 378.0% in the 2nd quarter. Janiczek Wealth Management LLC now owns 282 shares of the medical instruments supplier’s stock worth $50,000 after buying an additional 223 shares in the last quarter. Point72 Hong Kong Ltd bought a new stake in shares of ICU Medical in the 1st quarter worth about $94,000. Finally, Van ECK Associates Corp raised its position in shares of ICU Medical by 16.1% during the 1st quarter. Van ECK Associates Corp now owns 469 shares of the medical instruments supplier’s stock valued at $104,000 after buying an additional 65 shares in the last quarter. Hedge funds and other institutional investors own 90.20% of the company’s stock.

ICU Medical Stock Down 4.2 %

Shares of NASDAQ ICUI opened at $158.64 on Tuesday. ICU Medical, Inc. has a 1 year low of $128.90 and a 1 year high of $251.77. The firm has a 50-day simple moving average of $152.08 and a two-hundred day simple moving average of $166.33. The company has a market cap of $3.80 billion, a P/E ratio of -101.69 and a beta of 0.54. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.45 and a quick ratio of 1.25.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Raymond James cut ICU Medical from an “outperform” rating to a “market perform” rating in a research note on Tuesday, November 8th. KeyCorp cut their target price on ICU Medical from $225.00 to $200.00 in a research report on Tuesday, November 8th. Finally, StockNews.com downgraded ICU Medical from a “hold” rating to a “sell” rating in a research report on Wednesday, November 9th.

About ICU Medical

(Get Rating)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.

Recommended Stories

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUIGet Rating).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.